51 – 60 of 73
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Efficacy and Safety of Umeclidinium/Vilanterol in Current and Former Smokers with COPD : A Prespecified Analysis of The EMAX Trial
- Contribution to journal › Article
-
Mark
Human Primary Airway Basal Cells Display a Continuum of Molecular Phases from Health to Disease in Chronic Obstructive Pulmonary Disease
- Contribution to journal › Article
-
Mark
Perinatal inflammation relates to early respiratory morbidity and lung function at 12 years of age in children born very preterm
- Contribution to journal › Article
-
Mark
Eosinophilic and Noneosinophilic Asthma : An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma Cohort
- Contribution to journal › Article
-
Mark
Lung Mast Cells Have a High Constitutive Expression of Carboxypeptidase A3 mRNA That Is Independent from Granule-Stored CPA3
- Contribution to journal › Article
-
Mark
Immune modulation via T regulatory cell enhancement : Disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases—An EAACI position paper of the Task Force on Immunopharmacology (TIPCO)
- Contribution to journal › Article
-
Mark
Crosstalk between mast cells and lung fibroblasts is modified by alveolar extracellular matrix and influences epithelial migration
- Contribution to journal › Article
-
Mark
Cognitive dysfunction and quality of life during pollen season in children with seasonal allergic rhinitis
- Contribution to journal › Article
- 2020
-
Mark
Allergic respiratory disease care in the COVID-19 era : A EUFOREA statement
- Contribution to journal › Letter
-
Mark
Early and sustained symptom improvement with umeclidinium/vilanterol versus monotherapy in COPD : a post hoc analysis of the EMAX randomised controlled trial
- Contribution to journal › Article
